Dose escalation trial of BNT152+153 in patients with cancer
BNT152-01C
Phase 1 other active
Quick answer
Dose escalation trial of BNT152+153 in patients with cancer for Various solid tumors that are metastatic or unresectable is a Phase 1 program (other) at BioNTech Manufacturing GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioNTech Manufacturing GmbH
- Indication
- Various solid tumors that are metastatic or unresectable
- Phase
- Phase 1
- Modality
- other
- Status
- active